Livvy is a registered nurse (RN) and board-certified nurse midwife (CNM) in the state of New Jersey. After giving birth to her newborn daughter, Livvy stepped down from her full-time position at the Children’s Hospital of New Jersey. This gave her the opportunity to spend more time writing articles on all topics related to pregnancy and prenatal care.
CBD-drug interactions are also possible, so we encourage you to visit a doctor knowledgeable about CBD and cannabis to avoid these interactions. A qualified professional will also help you establish the right dosage regime to maximize the benefits of your treatment.
People with bipolar disorder often show intense symptoms of mania, during which they feel highly motivated and filled with energy. In a 1998 study published in the Journal of Psychoactive Drugs, the authors concluded that cannabis users responded better to their herbal treatment than those given conventional medications. The study mentioned CBD as a promising treatment for bipolar disorder, although the results came from only one type of the condition — hypomania (3).
CBD is praised for its ability to stabilize mood and alleviate anxiety. Anecdotal reports, as well as clinical evidence, indicate that CBD produces the same effects as some other bipolar medication and antidepressants.
However, lithium also has dangerous side effects. Approximately 70% of bipolar patients treated with lithium experience negative reactions. Although most of them are minor, common side effects of taking lithium include acne, diarrhea, poor memory, and weight gain. High doses of lithium are associated with ringing ears, poor muscle control, and blurry vision. Hypothyroidism is another potential side effect of long-term lithium treatment. It can also give rise to rare but severe kidney illnesses. None of these side effects were observed during the studies examining the safety and efficacy of CBD.
Finding the optimal dosage range for your situation will require some experimenting. Everybody is different, so a dose that works for your friend may not necessarily be enough to relieve your symptoms. Self-testing is an inevitable part of that process, but the goal is to minimize the number of errors.
Consistency is an essential component of successful bipolar disorder treatment. Only by being consistent can you manage the symptoms of the condition and level the endocannabinoid deficiencies in your system, which is one of the probable causes of bipolar disorder.
How Often Should You Take CBD for Bipolar?
For the best results, you should take CBD a few times a day depending on the route of administration. CBD oils provide relatively long-lasting effects, up to 6 hours, allowing the user to split the dosage into two servings. For products like CBD hemp flowers or CBD vapes, you’ll probably need to use them more often, as vaporized CBD has a shorter duration, usually between 3–4 hours.
The driving force behind the functioning of neurotransmitters and their matching receptors is called the endocannabinoid system (ECS). The discovery of the ECS has given researchers new insight into the interaction between different chemicals in your body; what happens when the communication system fails; and how to potentially restore the neurochemical homeostasis.
Four of the included studies did not report any adverse effects of CBD among patients with psychosis. CBD was well-tolerated in these patients except for mild transient sedation, hyperlipidemia, and gastrointestinal distress. Patients with schizophrenia had fewer instances of extrapyramidal symptoms, less weight gain, and a lower increase in prolactin levels.
The present review included three RCTs (107 patients), two open-label trials (28 patients), one case series of four patients, and two case reports for cannabis-related disorders as summarized in Table 2 (Solowij et al., 2018; Crippa et al., 2013; Trigo et al., 2016a; Trigo et al., 2018; Trigo et al., 2016b; Allsop et al., 2014; Pokorski et al., 2017; Shannon & Opila-Lehman, 2015). Of the eight studies, level 2 evidence was found in three RCTs, level 3 evidence in two clinical trial, and level 4 evidence in two case reports and one case series (OCEBM, 2019). For cannabis-related disorders, there is Grade B recommendation based on majority of studies ranked at the level 2 and level 3 of evidence.
CBD and CBD-containing compounds such as nabiximols were helpful in alleviating psychotic symptoms and cognitive impairment in patients with a variety of conditions, and several studies provided evidence of effectiveness in the treatment of cannabis withdrawal and moderate to severe cannabis use disorder with Grade B recommendation. There is Grade B recommendation supporting the use of CBD for the treatment of schizophrenia, social anxiety disorder and autism spectrum disorder (ASD), and attention deficit hyperactivity disorder (ADHD). Grade C recommendation exists for insomnia, anxiety, bipolar disorder, posttraumatic stress disorder, and Tourette syndrome. These recommendations should be considered in the context of limited number of available studies.
Data extraction and grading
Nabiximols produced improvements in patients with Tourette syndrome at a much lower dose than what was used for cannabis-related disorders (Trainor et al., 2016; Pichler et al., 2019). These case reports tested two oromucosal nabiximols sprays used twice a day (total dose 10.8 mg Δ9-THC and 10 mg CBD per day) (Trainor et al., 2016), and the second also tested cannabis tincture (34 drops three times a day (Pichler et al., 2019). Both case reports found improvements in tic frequency (Trainor et al., 2016; Pichler et al., 2019), severity (Trainor et al., 2016; Pichler et al., 2019), quality of life, and social activity (Trainor et al., 2016). These treatments regimens were used for 4 weeks with the oromucosal spray form (Trainor et al., 2016) and 8 weeks for cannabis tincture (Pichler et al., 2019). The therapeutic benefits can be attributed to the anxiolytic and sleep-inducing properties of CBD (Trainor et al., 2016). It is difficult to ascertain whether these improvements were due to due to CBD, Δ9-THC, additive, or synergetic effects. The anxiolytic properties of CBD explain the attenuation of anxiety associated with the onset of tics, and the improvement in tics with a combination of Δ9-THC and CBD (Trainor et al., 2016; Pichler et al., 2019).
CBD and CBD-containing compounds such as nabiximols were helpful in alleviating symptoms of cannabis-related disorders, schizophrenia, social anxiety disorder, and comorbidities of ASD, and ADHD with moderate recommendation. However, there is weaker evidence for insomnia, anxiety, bipolar disorder, posttraumatic stress disorder, and Tourette syndrome. The evidence for the use of CBD and CBD-containing compounds for psychiatric disorders needs to be explored in future studies, especially large-scale and well-designed RCTs.
Results & discussion
In a 10-year-old patient, 5 months of treatment with CBD oil (25 mg) and liquid CBD (6–12 mg) in a sublingual spray as needed was associated with less anxiety and better sleep quality, with no adverse effects (Shannon & Opila-Lehman, 2016). These results were replicated for anxiety in a recently published chart review of 72 adult patients with insomnia and anxiety (Shannon et al., 2019). Most patients in this group were given 25 mg CBD/day, while a few patients were given 50 or 75 mg/day, and one patient with schizoaffective disorder and trauma was given up to 175 mg/day. All patients showed less anxiety and improved sleep, with reductions of 65–80% in the Hamilton Anxiety Rating Scale and Pittsburgh Sleep Quality Index scores.
One case report on the use of CBD by two patients with bipolar disorder showed limited to no improvement with doses of 600–1200 mg for bipolar mania in one of the patients (Shannon et al., 2019). The second patient was prescribed CBD 600 mg (5–9 days) and olanzapine (10–15 mg), followed by CBD 900–1200 mg (20–33 days), and showed improvement on the Brief Psychiatric Rating Scale (37% reduction) and Young Mania Rating Scale (33% reduction) with CBD and olanzapine, but no additional improvement with CBD monotherapy (Shannon et al., 2019). This effect was consistent with results from animal studies that modeled acute mania with dextroamphetamine (Shannon et al., 2019). The lack of effectiveness can be attributed to the shorter duration of treatment in both cases. This evidence from studies of bipolar mania should be considered in the context of different pharmacological agents responding differently to certain episodes of bipolar disorder. In animal studies, CBD induced a rapid, persistent antidepressant response by increasing brain-derived neurotrophic factor in the prefrontal cortex (Shannon et al., 2019). Given its possible antidepressant benefits, the role of CBD should be explored in unipolar and bipolar depression.
Bipolar mood disorders can be quite tricky to treat. Like most mental disorders, medications have various side effects and some have adverse drug interactions. Regular check-ups with psychiatrists are needed to titrate one’s doses and mix of meds.
One of the compounds getting a lot of traction as a potential new treatment for bipolar disorder is cannabidiol — one of the primary phytochemicals in the cannabis plant.
Carrie Fisher is an American actress, writer, and comedian best known for playing the iconic Princess Leia in the Star Wars franchise. Catherine Zeta-Jones is an Academy and BAFTA award-winning Welsh actress known. You may have seen her in the movie musical Chicago or the heist film Entrapment. American singer-songwriter Halsey (birth name Ashley Nicolette Frangipane) has sold over 1 million albums and has been streamed over 6 billion times in the US alone.
Kyoto Botanicals offer CBD products so their consumers can find harmony and balance in their lives and positively shape the world and those around them to be better versions of themselves every day. The company is grounded in family roots and a firm belief that small things make a big impact. KYOTO BOTANICALS believes in giving back to the community and is dedicated to building a brand that can impact local and global needs.
Aside from being powerful, talented, globally renowned women, what else do these three have in common? They were all diagnosed with a bipolar mood disorder at a young age and their struggles with the disease have been well-documented by media.
CBD as Treatment For Bipolar Mood Disorder
Using full-spectrum hemp extract, organic coconut MCT oil, and organic spearmint leaf oil, KYOTO BOTANICALS REST(ful) Spearmint Tincture helps support an overall sense of peace and calmness to encourage your mind and body to relax throughout the day.
Hemp is fully legal in the United States and is determined by the government as having less than 0.3% THC content. All Kyoto Botanicals products are made with less than 0.3% THC, are classified as hemp, and are legal to use in all 50 states. They will also help you maintain a balanced phytocannabinoid profile.